University of Tennessee Cancer Institute Univ Tennessee Cancer — Memphis, Tennessee

University of Tennessee Cancer Institute Univ Tennessee Cancer is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute Univ Tennessee Cancer has participated in 1 clinical trials.

Therapeutic areas: Hodgkin Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute Univ Tennessee Cancer?

University of Tennessee Cancer Institute Univ Tennessee Cancer has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute Univ Tennessee Cancer conducted?

University of Tennessee Cancer Institute Univ Tennessee Cancer has 1 clinical trials on record. Their work covers Hodgkin Lymphoma.

Is University of Tennessee Cancer Institute Univ Tennessee Cancer accredited by Crixeo Health?

University of Tennessee Cancer Institute Univ Tennessee Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Cancer Institute Univ Tennessee Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.